Ohio State Navbar


Erin Macrae, MD

Current OSU Appointments

  • Assistant Professor, Internal Medicine, College of Medicine

Education and Training

  • Bachelor of Science, The Ohio State University
  • M.D., Case Western Reserve University
  • Internal Medicine Residency, Hospital of the University of Pennsylvania
  • Hematology and Oncology Fellowship, Dana-Farber Cancer Institute
Dr. Macrae joined the Division of Solid Tumor Oncology in 2011. Her research interests include experimental therapeutics and the role of biomarker-driven investigation of novel therapeutics in patients with advanced breast cancer. She is currently pursuing a Master of Public Health with a specialization in Clinical Investigation.  She serves as principal investigator on several innovative trials including an investigator-initiated phase II CTEP-sponsored clinical trial of a MEK and PI3 Kinase inhibitors in women diagnosed with advanced triple negative metastatic disease.  Inhibiting both pathways is a promising new therapeutic strategy for these difficult to treat triple negative breast cancers. She also serves as principal investigator on a trial that is sequencing of tumor DNA to identify cancers with gene mutations that have commercially available drugs that target these gene mutations.  Dr. Macrae provides clinical care to women with all stages of invasive breast cancer.